Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8249746
Reference Type
Journal Article
Title
ééç³æçè²ç±»æè¿ç¤æ´»æ§æåç ç©¶
Author(s)
Zhou, W; Zeng, QF; Xia, J; Wang, L; Tao, L; Shen, XC
Year
2018
Is Peer Reviewed?
0
Journal
Zhongguo Yaoxue Zazhi
ISSN:
1001-2494
Publisher
Chinese Pharmaceutical Association
Volume
53
Issue
20
Page Numbers
1722-1725
Language
Chinese
DOI
10.11669/cpj.2018.20.004
Abstract
OBJECTIVEï¼ To study the antitumor phenanthrene constituents in Dendrobium nobile.METHODSï¼ A variety of chromatographic techniques were applied to extract, isolate and purify natural products from extract of Dendrobium nobile, their structures were identified on the basis of spectral data. The antitumor activity of these monomers in MCF-7 breast cancer cells was studied by MTT assay in vitro. RESULTSï¼ Nine compounds were isolated from ethyl acetate part in Dendrobium nobile, there were four phenanthrene compounds, which were densiflorol B(1), cypripedin(2), moscatin(3) and 2,4,8-trimethoxy phenanthrene-3,7-diol(4); three coumarin compounds: coumarin(5), moellendorffiline(6) and isopimpinellin(7); one flavanoid: naringenin(8); one phenol: (E)-4-(2-methoxyvinyl) benzene-1,2-diol(9). Compounds 1-3 had good antitumor activities, their IC50 values were 2.99, 5.01 and 72.68 μmolâ¢L-1 respectively. CONCLUSIONï¼ The compounds 6, 7, 9 are isolated from the Orchidaceae family for the first time, compounds 1, 2, 4, 5, 8 are isolated from this plant for the first time. Compounds 1-3 can be used as candidates for anti-tumor drugs. Copyright 2018 by the Chinese Pharmaceutical Association.
Keywords
Antitumor; Cypripedin; Dendrobium nobile; Densiflorol B; Phenanthrene
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity